NIH Prize Links Liberal Arts and Brain Trauma

One doesn’t usually connect liberal arts graduate students with neuroscience research, but now Penn has.

Two Master of Liberal Arts students from Penn’s College of Liberal and Professional Studies were winners in the National Institute of Health’s (NIH) Neuro Startup Challenge. The NIH developed the challenge to attract students to create launch campaigns for its unlicensed technologies, all of which treat brain-related illnesses.

Krystle Karoscik and Medha Sengupta, who will earn their Penn graduate degrees in August, are now working to market a device that simulates a blast-induced traumatic brain injury (TBI), offering hope for the future diagnosis and treatment of TBIs. This new technology is unique because of its ability to examine and record—on a cellular level—what occurs when brain cells are exposed to a blast from an explosive device.

Because the device allows them to adjust and record a blast’s effect in real time, they can track and compare any cellular changes. “It is very difficult to diagnose a TBI,” Karoscik says. “Without a proper diagnosis, it is challenging to provide an effective treatment to the injured individual.” Sengupta adds, “Because we’re able to record what’s happening on a cellular level, we will have more data to share with the physicians treating TBI patients.”

The two entrepreneurs met in January 2013 while working at the Clinical Cell and Vaccine Production Facility at Penn Medicine and began their Master of Liberal Arts programs in 2014. Karoscik’s concentration is neurosciences and bioethics. She currently works at The Children’s Hospital of Philadelphia as a project manager in the Department of Neurology and oversees the initiation and maintenance of research studies for pediatric demyelinating diseases. She plans to apply to Penn to earn her Ph.D., matriculating in 2016. Sengupta’s concentration is in neurobiology and public health. She works at Penn’s School of Medicine as a clinical coordinator, overseeing the quality assurance of clinical trials for cancer. They have named their company Amavii, which comes from the Italian and Latin words for love and compassion. They are working to incorporate the business and apply for licensing.

Click here Neuro Startup Challenge to learn more about the Neuro Startup Challenge.

Arts & Sciences News

Marisa C. Kozlowski Named Next Associate Dean for the Natural Sciences

Kozlowski, who joined the Penn faculty in 1997, succeeds Mark Trodden, who transitions to the Dean of Penn Arts & Sciences on June 1.

View Article >
One Fourth Year, One Alum Receive 2025 Hertz Fellowship

Eric Tao, C’25, Gr’25 (left), and Suraj Chandran, C’23, were awarded the honor, part of a group of 19 fellows selected this year. Each one receives five years of funding toward a doctoral program.

View Article >
Benjamin Nathans Wins 2025 Pulitzer Prize in General Nonfiction

Nathans, Alan Charles Kors Endowed Term Professor of History, won for his book “To the Success of Our Hopeless Cause: The Many Lives of the Soviet Dissident Movement.”

View Article >
Mark Devlin Elected to National Academy of Sciences

He joins three others from Penn to receive the honor this year, all recognized for “distinguished and continuing achievements in original research.”

View Article >
Michael Jones-Correa and Sophia Rosenfeld Elected to American Academy of Arts & Sciences

They join three others from the University of Pennsylvania, selected as part of the Academy’s mission to convene leaders from “every field of human endeavor to examine new ideas, address issues of importance to the nation and the world, and work together.”

View Article >
Eva Del Soldato Awarded 2025-26 Rome Prize

She joins Sean Burkholder, of the Weitzman School of Design, and just 33 others in receiving the prestigious honor from the American Academy in Rome.

View Article >